Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vfend vs Itraconazole for IFI Prophylaxis in HSCT
NCT00289991Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2006
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
- Countries
- 12
01
Overview
A Phase 3 trial of voriconazole in invasive fungal infection (IFI), sponsored by Pfizer. Started Mar 2006; status: completed.
02
Drugs
voriconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00289991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289991.